Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have ...

The global pandemics of plague and smallpox in the Middle Ages claimed hundreds of millions of lives. In this era, long before the concepts of pathogens and infectious diseases were established, ...

Atrial fibrillation (AF) is the most common arrhythmia and is a leading cause of stroke and heart failure yet often remains undiagnosed. Screening has been proposed to identify asymptomatic AF and ...

Obesity is an independent driver of cardiovascular disease (CVD), mediated through adverse haemodynamic loading, insulin resistance, systemic inflammation, endothelial dysfunction and prothrombotic ...

1 Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK 2 Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, UK Correspondence to Clare Teresa ...

5 Department of Heart Disease, Haukeland University Hospital, and Institute of Medicine, University of Bergen, Bergen, Norway 6 Department of Clinical and Experimental Medicine, Federico II, ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Professor Patrick Vallance, Centre of Clinical Pharmacology, Gower Street Campus, 3rd Floor, Rayne Institute, 5 University Street, London WC1E 6JJ, UKpatrick.vallance{at}ucl.ac.uk If you wish to reuse ...

At present there is no universally accepted nomenclature for congenital cardiac malformations. Much of the controversy results from failure to distinguish the structural connections of the heart from ...

Aims In people with heart failure (HF), a high body mass index (BMI) has been linked with better outcomes (‘obesity paradox’), but there is limited evidence in community populations across long-term ...

International Centre for Circulatory Health, 10th Floor QEQM Wing, St Mary’s Hospital, and Imperial College Paddington and Clinical Pharmacology, NHLI, Imperial College of Science, Technology & ...

Correspondence to Dr Rohan S Wijesurendra, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK; rohan.wijesurendra{at}cardiov.ox.ac.uk; Professor ...